These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 13524118)

  • 1. Prochlorperazine in hospitalized and private psychiatric patients.
    WILCOX F
    Dis Nerv Syst; 1958 Mar; 19(3):118-21. PubMed ID: 13524118
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of ambulatory and hospitalized psychiatric patients with trilafon.
    AYD FJ
    Dis Nerv Syst; 1957 Oct; 18(10):394-7. PubMed ID: 13473680
    [No Abstract]   [Full Text] [Related]  

  • 3. [Status of patients hospitalized in private psychiatric hospitals for a prolonged period and policies managing them].
    Igarashi Y
    Seishin Shinkeigaku Zasshi; 2004; 106(5):645-53. PubMed ID: 15307279
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of psychiatric disorders in mental defectives with perphenazine.
    SPROGIS GR; BABCOCK SD; SEGALL J
    J Med Soc N J; 1958 Mar; 55(3):120-3. PubMed ID: 13514429
    [No Abstract]   [Full Text] [Related]  

  • 5. The neuroleptic action and effectiveness of proclorperazine in psychiatric disorders.
    FREYHAN FA
    Psychiatr Res Rep Am Psychiatr Assoc; 1958 Mar; 9():32-45. PubMed ID: 13567917
    [No Abstract]   [Full Text] [Related]  

  • 6. [Notes on the use of a new phenothiazine derivative, perphenazine, in neuro-psychiatric practice].
    LARICCHIA R; BASEVI A
    Minerva Med; 1958 May; 49(39, Suppl.):1993-5. PubMed ID: 13565614
    [No Abstract]   [Full Text] [Related]  

  • 7. One hundred private psychiatric patients.
    Munoz RA
    Dis Nerv Syst; 1974 Aug; 35(8):358-61. PubMed ID: 17894072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of placebos in a psychiatric observation war as demonstrated by a clinical trial of a new phenothiazine derivative].
    LEHMANN H; RETTERSTOL N; SIRNES T
    Tidsskr Nor Laegeforen; 1958 Jun; 78(12):588-92. PubMed ID: 13569456
    [No Abstract]   [Full Text] [Related]  

  • 9. Involuntary hospitalizations of patients with mental disorders in Vrapce Psychiatric Hospital: five years of implementation of the first Croatian law on protection of persons with mental disorders.
    Kozumplik O; Jukić V; Goreta M
    Croat Med J; 2003 Oct; 44(5):601-5. PubMed ID: 14515421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental neurological syndromes and psychiatric therapy. II. Psychic and therapeutic effects of a new major neuroleptic, 7843 RP; polygraphic study].
    DELAY J; DENIKER P; ROPERT R; BEEK H; BARANDE R; EURIEULT M
    Presse Med (1893); 1959 Jan; 67(6):201-3. PubMed ID: 13633845
    [No Abstract]   [Full Text] [Related]  

  • 11. [Discharge curve among psychiatric patients after admission and risk factors associated with long stay based on "patient survey"].
    Fujita T; Takeshima T
    Seishin Shinkeigaku Zasshi; 2006; 108(9):891-905. PubMed ID: 17137193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Notes on liver function test in mental patients treated with promazine].
    PARDERA G
    Riv Patol Nerv Ment; 1957; 78(3):1106-8. PubMed ID: 13528805
    [No Abstract]   [Full Text] [Related]  

  • 13. [Utilization of injectable meprobamate in 45 hospitalized patients in psychiatric environment].
    CHARRIOT G; CHAPOT G; LAMBERT PA
    Lyon Med; 1960 Dec; 92():1325-44. PubMed ID: 13692523
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in the electroencephalogram caused by intravenous perphenazine in normal subjects and mental disease patients; preliminary note.
    NEGRI VU; BASEVI A
    Minerva Med; 1958 May; 49(39, Suppl.):1995-9. PubMed ID: 13565615
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical efficacy of proclorperazine (compazine) in mental illness.
    RIESENMAN FR; PETTIT MB
    Am J Psychiatry; 1959 May; 115(11):1032-3. PubMed ID: 13637287
    [No Abstract]   [Full Text] [Related]  

  • 16. Patterns of admission to acute psychiatric in-patient facilities: a national survey in Italy.
    Preti A; Rucci P; Santone G; Picardi A; Miglio R; Bracco R; Norcio B; de Girolamo G;
    Psychol Med; 2009 Mar; 39(3):485-96. PubMed ID: 18578893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient experiences with treatment in private practice compared with public mental health services.
    Bjørngaard JH; Garratt A; Gråwe RW; Bjertnaes OA; Ruud T
    Scand J Psychol; 2008 Aug; 49(4):385-92. PubMed ID: 18466189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of promazine in mental syndromes.
    AZIMA H; DUROST H
    Can Med Assoc J; 1957 Mar; 76(6):442-6. PubMed ID: 13413759
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the use of promazine in acute and chronic nervous and mental disturbances.
    BURDINE WE; SHIPLEY TE; PAPAS AT
    J Med Assoc Ga; 1957 Apr; 46(4):171-3. PubMed ID: 13416819
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevalence and type of dermatologic disorders in psychiatric patients treated with psychotropic drugs].
    Murak-Kozanecka E; Rabe-Jabłońska J
    Psychiatr Pol; 2004; 38(3):491-505. PubMed ID: 15199658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.